title: Randomised controlled trial of spinal anaesthesia with bupivacaine or 2-chloroprocaine during caesarean section.
abstract: BACKGROUND
  Neuraxial anaesthesia is the desired method for Caesarean section. Bupivacaine is a well-known local anaesthetic. It has a long duration of action and can cause unpredictable levels of anaesthesia with subsequent prolonged discharge time. 2-Chloroprocaine has a rapid onset of action, producing an excellent sensory and motor block and has a rapid hydrolysis in the bloodstream by pseudocholinesterase. We compared bupivacaine and 2-chloroprocaine for spinal anaesthesia during Caesarean section. The primary endpoint was the earliest reversal sign of the motor block.
  
  
  METHODS
  Sixty ASAI/II patients, planned for elective singleton Caesarean section, were equally randomised to three groups. All patients received a combined spinal-epidural anaesthesia. The first group received 2-chloroprocaine (40 mg) without sufentanil, the second group received 2-chloroprocaine (40 mg) with sufentanil (1 μg) and the third group received hyperbaric bupivacaine (7.5 mg) with sufentanil (1 μg) as a spinal anaesthetic. Motor and sensory blockade were assessed at specific time points.
  
  
  RESULTS
  There was no difference between the three groups regarding the time to regression of the motor block. However, at 5 min post spinal injection, the level of sensory block was higher for both groups with 2-chloroprocaine, in comparison with the bupivacaine group.
  
  
  CONCLUSIONS
  2-Chloroprocaine can be used for low risk Caesarean section in healthy parturients. There is no difference in time to motor block resolution compared to bupivacaine. Motor recovery seems more predictable for 2-chloroprocaine and may be beneficial for the breastfeeding initiation.
authors.affiliation: Department of Anaesthesiology and Perioperative Medicine, UZ Brussel, Brussels, Belgium.
authors.forename: S
authors.initials: S
authors.lastname: Maes
authors.affiliation: Department of Gynaecology, UZ Brussel, Brussels, Belgium.
authors.forename: M
authors.initials: M
authors.lastname: Laubach
authors.affiliation: Department of Anaesthesiology and Perioperative Medicine, UZ Brussel, Brussels, Belgium.
authors.forename: J
authors.initials: J
authors.lastname: Poelaert
mesh_terms: D000293:Adolescent; D000328:Adult; D000767:Anesthesia, Epidural / Q000379:methods*; D000773:Anesthesia, Obstetrical / Q000379:methods*; D000775:Anesthesia, Spinal / Q000379:methods*; D018686:Anesthetics, Intravenous; D000779:Anesthetics, Local; D001034:Apgar Score; D002045:Bupivacaine; D002585:Cesarean Section / Q000379:methods*; D023381:Endpoint Determination; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D009407:Nerve Block; D010147:Pain Measurement; D011247:Pregnancy; D011343:Procaine / Q000031:analogs & derivatives*; D017409:Sufentanil; D055815:Young Adult
chemical_list: D018686:Anesthetics, Intravenous; D000779:Anesthetics, Local; D011343:Procaine; C004616:chloroprocaine; D017409:Sufentanil; D002045:Bupivacaine